Enhancement of mesenchymal stem cell-driven bone regeneration by resveratrol-mediated SOX2 regulation

Yoorim Choi, Dong Suk Yoon, Kyoung Mi Lee, Seong Mi Choi, Myon Hee Lee, Kwang Hwan Park, Seung Hwan Han, Jin Woo Lee

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Mesenchymal stem cells (MSCs) are an attractive cell source for regenerative medicine. However, MSCs age rapidly during long-term ex vivoculture and lose their therapeutic potential before they reach effective cell doses (ECD) for cell therapy. Thus, a prerequisite for effective MSC therapy is the development of cell culture methods to preserve the therapeutic potential during long-term ex vivo cultivation. Resveratrol (RSV) has been highlighted as a therapeutic candidate for bone disease. Although RSV treatment has beneficial effects on bone-forming cells,invivostudies are lacking.The current study showed that long-term (6 weeks from primary culture date)-cultured MSCs with RSV induction retained their proliferative and differentiation potential despite reaching ECD. The mechanism of RSV action depends entirely on the SIRT1-SOX2 axis in MSC culture. In a rat calvarial defect model, RSV induction significantly improved bone regeneration after MSC transplantation. This study demonstrated an example of efficient MSC therapy for treating bone defects by providing a new strategy using the plant polyphenol RSV.

Original languageEnglish
Pages (from-to)818-833
Number of pages16
JournalAging and Disease
Volume10
Issue number4
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Bone Regeneration
Mesenchymal Stromal Cells
Cell- and Tissue-Based Therapy
Cell Culture Techniques
Mesenchymal Stem Cell Transplantation
Bone and Bones
Regenerative Medicine
Bone Diseases
Polyphenols
Therapeutics
resveratrol

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Geriatrics and Gerontology
  • Clinical Neurology
  • Cell Biology

Cite this

Choi, Yoorim ; Yoon, Dong Suk ; Lee, Kyoung Mi ; Choi, Seong Mi ; Lee, Myon Hee ; Park, Kwang Hwan ; Han, Seung Hwan ; Lee, Jin Woo. / Enhancement of mesenchymal stem cell-driven bone regeneration by resveratrol-mediated SOX2 regulation. In: Aging and Disease. 2019 ; Vol. 10, No. 4. pp. 818-833.
@article{322df00afdca4da3b9723ebb2704185f,
title = "Enhancement of mesenchymal stem cell-driven bone regeneration by resveratrol-mediated SOX2 regulation",
abstract = "Mesenchymal stem cells (MSCs) are an attractive cell source for regenerative medicine. However, MSCs age rapidly during long-term ex vivoculture and lose their therapeutic potential before they reach effective cell doses (ECD) for cell therapy. Thus, a prerequisite for effective MSC therapy is the development of cell culture methods to preserve the therapeutic potential during long-term ex vivo cultivation. Resveratrol (RSV) has been highlighted as a therapeutic candidate for bone disease. Although RSV treatment has beneficial effects on bone-forming cells,invivostudies are lacking.The current study showed that long-term (6 weeks from primary culture date)-cultured MSCs with RSV induction retained their proliferative and differentiation potential despite reaching ECD. The mechanism of RSV action depends entirely on the SIRT1-SOX2 axis in MSC culture. In a rat calvarial defect model, RSV induction significantly improved bone regeneration after MSC transplantation. This study demonstrated an example of efficient MSC therapy for treating bone defects by providing a new strategy using the plant polyphenol RSV.",
author = "Yoorim Choi and Yoon, {Dong Suk} and Lee, {Kyoung Mi} and Choi, {Seong Mi} and Lee, {Myon Hee} and Park, {Kwang Hwan} and Han, {Seung Hwan} and Lee, {Jin Woo}",
year = "2019",
month = "1",
day = "1",
doi = "10.14336/AD.2018.0802",
language = "English",
volume = "10",
pages = "818--833",
journal = "Aging and Disease",
issn = "2152-5250",
publisher = "International Society on Aging and Disease",
number = "4",

}

Enhancement of mesenchymal stem cell-driven bone regeneration by resveratrol-mediated SOX2 regulation. / Choi, Yoorim; Yoon, Dong Suk; Lee, Kyoung Mi; Choi, Seong Mi; Lee, Myon Hee; Park, Kwang Hwan; Han, Seung Hwan; Lee, Jin Woo.

In: Aging and Disease, Vol. 10, No. 4, 01.01.2019, p. 818-833.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Enhancement of mesenchymal stem cell-driven bone regeneration by resveratrol-mediated SOX2 regulation

AU - Choi, Yoorim

AU - Yoon, Dong Suk

AU - Lee, Kyoung Mi

AU - Choi, Seong Mi

AU - Lee, Myon Hee

AU - Park, Kwang Hwan

AU - Han, Seung Hwan

AU - Lee, Jin Woo

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Mesenchymal stem cells (MSCs) are an attractive cell source for regenerative medicine. However, MSCs age rapidly during long-term ex vivoculture and lose their therapeutic potential before they reach effective cell doses (ECD) for cell therapy. Thus, a prerequisite for effective MSC therapy is the development of cell culture methods to preserve the therapeutic potential during long-term ex vivo cultivation. Resveratrol (RSV) has been highlighted as a therapeutic candidate for bone disease. Although RSV treatment has beneficial effects on bone-forming cells,invivostudies are lacking.The current study showed that long-term (6 weeks from primary culture date)-cultured MSCs with RSV induction retained their proliferative and differentiation potential despite reaching ECD. The mechanism of RSV action depends entirely on the SIRT1-SOX2 axis in MSC culture. In a rat calvarial defect model, RSV induction significantly improved bone regeneration after MSC transplantation. This study demonstrated an example of efficient MSC therapy for treating bone defects by providing a new strategy using the plant polyphenol RSV.

AB - Mesenchymal stem cells (MSCs) are an attractive cell source for regenerative medicine. However, MSCs age rapidly during long-term ex vivoculture and lose their therapeutic potential before they reach effective cell doses (ECD) for cell therapy. Thus, a prerequisite for effective MSC therapy is the development of cell culture methods to preserve the therapeutic potential during long-term ex vivo cultivation. Resveratrol (RSV) has been highlighted as a therapeutic candidate for bone disease. Although RSV treatment has beneficial effects on bone-forming cells,invivostudies are lacking.The current study showed that long-term (6 weeks from primary culture date)-cultured MSCs with RSV induction retained their proliferative and differentiation potential despite reaching ECD. The mechanism of RSV action depends entirely on the SIRT1-SOX2 axis in MSC culture. In a rat calvarial defect model, RSV induction significantly improved bone regeneration after MSC transplantation. This study demonstrated an example of efficient MSC therapy for treating bone defects by providing a new strategy using the plant polyphenol RSV.

UR - http://www.scopus.com/inward/record.url?scp=85058930040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058930040&partnerID=8YFLogxK

U2 - 10.14336/AD.2018.0802

DO - 10.14336/AD.2018.0802

M3 - Article

AN - SCOPUS:85058930040

VL - 10

SP - 818

EP - 833

JO - Aging and Disease

JF - Aging and Disease

SN - 2152-5250

IS - 4

ER -